NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.verified

NRSNW

Price:

$0.18

Market Cap:

$23.95M

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline product candidates include StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

NASDAQ

Ticker

NRSNW

The Current Ratio as of November 2024 (TTM) for NeuroSense Therapeutics Ltd. (NRSNW) is 0.46

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.46. This represents a change of -45.46% compared to the average of 0.85 of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSNW) Historical Current Ratio (quarterly & annually)

How has NRSNW Current Ratio performed in the past?

The mean historical Current Ratio of NeuroSense Therapeutics Ltd. over the last ten years is 11.00. The current 0.46 Current Ratio has changed 319.67% with respect to the historical average. Over the past ten years (40 quarters), NRSNW's Current Ratio was at its highest in in the December 2021 quarter at 19.12. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

11.00

Median

6.08

Minimum

0.84

Maximum

24.68

NeuroSense Therapeutics Ltd. (NRSNW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 214.66%

Maximum Annual Current Ratio = 24.68

Minimum Annual Increase = -80.29%

Minimum Annual Current Ratio = 0.84

Quarterly (TTM)
Annual
YearCurrent RatioChange
20230.84-80.29%
20224.28-77.63%
202119.12214.66%
20206.08-75.38%

NeuroSense Therapeutics Ltd. (NRSNW) Average Current Ratio

How has NRSNW Current Ratio performed in the past?

The current Current Ratio of NeuroSense Therapeutics Ltd. (NRSNW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.08

5-year avg

11.00

10-year avg

11.00

NeuroSense Therapeutics Ltd. (NRSNW) Current Ratio vs. Peers

How is NRSNW’s Current Ratio compared to its peers?

NeuroSense Therapeutics Ltd.’s Current Ratio is less than NeuroSense Therapeutics Ltd. (0.46), less than Pasithea Therapeutics Corp. (6.20), less than GeoVax Labs, Inc. (0.60), greater than NLS Pharmaceutics AG (0.15), less than Cingulate Inc. (1.20),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSNW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSNW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is NeuroSense Therapeutics Ltd.'s Current Ratio?

How is the Current Ratio calculated for NeuroSense Therapeutics Ltd. (NRSNW)?

What is the highest Current Ratio for NeuroSense Therapeutics Ltd. (NRSNW)?

What is the 3-year average Current Ratio for NeuroSense Therapeutics Ltd. (NRSNW)?

What is the 5-year average Current Ratio for NeuroSense Therapeutics Ltd. (NRSNW)?

How does the current Current Ratio for NeuroSense Therapeutics Ltd. (NRSNW) compare to its historical average?